The Rs 3,866 crore pharma major Lupin Ltd is likely to go in for overseas acquisitions within 6 to 9 months. Lupin is negotiating with a few companies in Gulf, Mexico, Brazil and Argentina, as it intends to increase its footprint in newer markets. The acquisition would be of companies involved in pharma marketing or those who have a mix of marketing and manufacturing base.
The Mumbai-based company has been on a buying spree. It acquired a company, Kyowa, in Japan in 2007, followed by a Pharma Dynamics’ buy in South Africa in 2008 and the latest acquisition of Multicare Pharmaceutical in Philippines, earlier this year.
Lupin chairman Desh Bandhu Gupta hinted last year that the company was eyeing acquisitions in Middle East and
Latin America to bolster its presence in this market. Now, the plan has taken a concrete shape, with recessionary sentiment waning in the overseas markets.
crackcrack